As we approach 2025, hyper automation continues to drive transformative alternatives throughout industries. Hyper automation, the aggregate of superior technology like artificial intelligence, machine ...

NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been positioned by Gartner, Inc. as a Leader in the 2025 Gartner® Magic Quadrant™ for ...

For decades, the OT world has had to navigate the challenges of proprietary systems and vendor lock-in as they pined for solutions modeled on the open standards and interoperability precedents that ...

On the cusp of a new year, enterprise IT faces a fascinating conundrum: One of the least automated functions in any company is IT itself. I expect that to change, though it won’t always make for a ...

Adam Gurga is national manager of grocery and retail partnerships with Cimcorp, a pioneer of intralogistics automation, specialized in fresh food handling and tire-handling solutions. It’s safe to say ...

Robotic process automation (RPA) has emerged as a pivotal tool for efficiency and productivity in modern businesses. Used in applications ranging from system navigation to data extraction, software ...

The integration of generative AI (GenAI) into tools such as cloud-based SaaS (software-as-a-service) products are driving dynamic transformation in the industrial automation space. The emergence of ...

Dow has a diverse portfolio of manufacturing chemical and power plants and a rich heritage of process automation to run them. As facilities grow and expand, they tend to accumulate a wide range of ...

Pete Hogg is an experienced B2B marketer and expert advisor to start-ups and SMEs on AI and automation strategies at MQLFlow. In the evolving world of marketing, automation has long been heralded as a ...

When used for customer service, IPA enhances the customer experience with quick response times, round-the-clock availability, and virtually no human errors. Intelligent process automation (IPA) blends ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...